The Pharmacology of GYKI‐46 903, a New Cognition Enhancer

CNS drug reviews Pub Date : 1995-09-01 DOI:10.1111/J.1527-3458.1995.TB00280.X

B. Vitális A. Bakonyi V. Csillik-Perczel E. Horváth K. Horváth I. Máté S. Sólyom T. Yemane G. Ábrahám J. Székely L. G. Hársing

引用次数: 2

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

新型认知增强剂GYKI - 46 903的药理作用

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

相关文献

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasm

IF 4.8 2区医学American heart journalPub Date : 1979-09-01 DOI: 10.1016/0002-8703(79)90053-X

William Frishman M.D. , Richard Davis M.D., Joel Strom M.D., Uri Elkayam M.D., Morris Stampfer M.D., Hillel Ribner M.D., Jerome Weinstein M.D., Edmund Sonnenblick M.D.

MOLECULAR MECHANISMS MEDIATING THE EFFECT OF A NEW COGNITION ENHANCER, L‐ALPHA‐GLYCERYLPHOSPHORYLCHOLINE, ON BEHAVIOURAL AND BIOCHEMICAL PARAMETERS, IN YOUNG AND AGED RATS.

IF 1 4区医学Clinical NeuropharmacologyPub Date : 1992-01-01 DOI: 10.1097/00002826-199202001-00255

G. Schettini, C. Ventra, T. Florio, O. Meucci, M. Grialdi, A. Scorziello, A. Avallone, A. Marino

The Pharmacology of GYKI-46 903, a New Cognition Enhancer

IF 0 CNS drug reviewsPub Date : 1995-09-01 DOI: 10.1111/j.1527-3458.1995.tb00280.x

Beáta Vitális, Anna Bakonyi, Viola Csillik-Perczel, Edit Horváth, Katalin Horváth, Ildikó Máté, József I. Székely, Tilahun Yemane, Gizella Abraham, Sándor Sólyom, Lázló G. Hársing Jr.

来源期刊

CNS drug reviews

自引率

0.00%

发文量

期刊最新文献

A Review of the Neurotrophic and Neuroprotective Properties of ONO-1603: Comparison with Those of Tetrahydroaminoacridine, an Antidementia Drug Effects of Azaindolizindone Derivatives ZSET845 and ZSET1446 on Acetylcholine Release in the Cortex and Learning Impairments in the Rat 7th International Conference AD/PD 2005, Sorrento, Italy, March 9–14, 2005 Symptomatic and Disease Modifying Treatments of Alzheimer's Disease SB-236057-A: a selective 5-HT1B receptor inverse agonist.